The steamy summer heat in Washington, DC, was no match for the hothouse of ideas and innovations on display at the recent 46th Annual DIA Meeting. The event was well attended by all levels of Life Sciences professionals. Because this premier event for the pharmaceutical & biotech industry draws the industry’s best minds from around the world, it was no surprise that many of the discussions in the hallways, meeting rooms and social events revolved around the increasingly global nature of clinical trials. The impact of this expansion is already being felt — and a lot of the talk was about how this will play out in the future.
